Clinical Trial Update: A Large Language Model-based Chatbot for Alcohol Reduction in Patients With Metabolic Alcohol-Related Liver Disease [NA]

View source ↗

Summary

Ongoing clinical trial evaluating a large language model–based chatbot to reduce alcohol use in patients with metabolic liver disease, with recruitment currentl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Metabolic Alcohol-related Liver Disease
• Metabolic Dysfunction-associated Steatotic Liver Disease

Snippet

Sponsor: The University of Hong Kong | Conditions: Metabolic Dysfunction-Associated Steatotic Liver Disease, Metabolic Alcohol-Related Liver Disease | NA | Status: RECRUITING